Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Signature - Title
Wu Yifang - Director
Location
Shanghai, China
Summary
This page shows a list of all the recent 13F filings made by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. didn't report any stock holdings as of Q3 2023. Fosun International Ltd is reporting for Shanghai Fosun Pharmaceutical (Group) Co., Ltd..

Fosun International Ltd is reporting for Shanghai Fosun Pharmaceutical (Group) Co., Ltd.:

Name Holdings Value Location File Number
Fosun International Ltd $304M Hong Kong, China 028-15992